Patient perspective: Is intensive screening of women at high risk of breast cancer evidence-based medicine or ?

In 2023, a breast cancer risk assessment and a subsequent positive test for the BRCA-2 genetic mutation brought me to the uncomfortable intersection of a longstanding career as an advocate for high-quality medical evidence to support shared patient-provider decision making and a new role as a high-r...

Full description

Saved in:
Bibliographic Details
Main Author: Kathleen A Fairman
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Women's Health
Online Access:https://doi.org/10.1177/17455057241307089
Tags: Add Tag
No Tags, Be the first to tag this record!